Concepedia

Glucuronidation of Monohydroxylated Warfarin Metabolites by Human Liver Microsomes and Human Recombinant UDP-Glucuronosyltransferases

A. Zielińska, Cheryl F. Lichti, Stacie M. Bratton, Neil C. Mitchell, Anna Gallus‐Zawada, Vi-Huyen Le, Moshe Finel, Grover P. Miller, Anna Radomińska‐Pandya, Jeffery H. Moran

Journal of Pharmacology and Experimental Therapeutics · 2007 · 43 citations · 21 references

DOIFull text

Open access

Concepts

References

21

Hydroxylation of warfarin by human cDNA-expressed cytochrome P-450: a role for P-4502C9 in the etiology of (S)-warfarin-drug interactions

Allan E. Rettie, Kenneth R. Korzekwa, Kent L. Kunze et al. · Chemical Research in Toxicology · 1992 · 602 citations

, , +17

The role of the CFP2C9-Leu 359 allelic variant in the tolbutamide polymorphism

Theresa H. Sullivan-Klose, Burhan I. Ghanayem, Douglas A. Bell et al. · Pharmacogenetics · 1996 · 587 citations

, , +17

Human UGT2B7 catalyzes morphine glucuronidation.

Birgit L. Coffman, Gladys R. Rios, Christopher D. King et al. · PubMed · 1997 · 426 citations

, , +11

GLUCURONIDATION CONVERTS GEMFIBROZIL TO A POTENT, METABOLISM-DEPENDENT INHIBITOR OF CYP2C8: IMPLICATIONS FOR DRUG-DRUG INTERACTIONS

Brian W. Ogilvie, Donglu Zhang, Wenying Li et al. · Drug Metabolism and Disposition · 2005 · 329 citations

, , +17

Differential Expression of the UGT1A Locus in Human Liver, Biliary, and Gastric Tissue: Identification ofUGT1A7 and UGT1A10 Transcripts in Extrahepatic Tissue

Christian P. Strassburg, Karl J. Oldhafer, Michael P. Manns et al. · Molecular Pharmacology · 1997 · 281 citations

, , +8